Insider Shareholders with Direct Ownership of Gossamer Bio, Inc. (GOSS)
This section provides a comprehensive overview of the insiders with direct ownership of Gossamer Bio, Inc. (GOSS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Gossamer Bio, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Faheem Hasnain
President & CEO |
880,000 | 42,207 | 837,793 $2.27 Million | 5 |
Jan 02, 2026
Added 25.05%
|
|
Waage Christian
EVP, Tech Ops and Admin |
254,500 | 22,642 | 814,061 $2.21 Million | 6 |
Jan 02, 2026
Added 9.4%
|
|
Richard Aranda
Chief Medical Officer |
271,250 | 30,493 | 463,106 $1.26 Million | 11 |
Jan 02, 2026
Added 16.84%
|
|
Bryan Giraudo
COO/CFO |
342,000 | 22,642 | 389,737 $1.06 Million | 6 |
Jan 02, 2026
Added 22.9%
|
|
Robert Paul Smith Jr
Chief Commercial Officer |
256,250 | 0 | 260,898 $707,033 | 2 |
Jan 02, 2026
Added 26.43%
|
|
Caryn Peterson
EVP, Regulatory Affairs |
220,320 | 24,995 | 259,333 $702,792 | 8 |
Jan 02, 2026
Added 24.58%
|
|
Luisa Salter Cid
Chief Scientific Officer |
45,000 | 5,491 | 206,065 $558,436 | 2 |
Mar 23, 2021
Reduced 2.6%
|
|
Laura Carter
Chief Scientific Officer |
42,754 | 28,354 | 76,263 $206,672 | 9 |
Mar 16, 2023
Reduced 7.33%
|
|
Sandra Milligan
Director |
26,050 | 0 | 58,050 $157,315 | 1 |
Aug 19, 2025
Added 30.98%
|